Nomura Securities initiates coverage on Celgene (NASDAQ: CELG) with a Buy. PT $236.00.

"Celgene is focused on development of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE